Postmenopausal Vaginal Atrophy - Market Insights, Epidemiology and Market Forecast - 2025

Publisher Name :
Date: 01-Nov-2017
No. of pages: 70
Price : Single User: US $ 5750  US $ 4600 Corporate User: US $ 17250  US $ 10350
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Postmenopausal Vaginal Atrophy - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Postmenopausal Vaginal Atrophy for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Postmenopausal Vaginal Atrophy . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Postmenopausal Vaginal Atrophy for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Postmenopausal Vaginal Atrophy market, as well as treatment algorithm, current treatments & advancements are included.The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Postmenopausal Vaginal Atrophy , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Postmenopausal Vaginal Atrophy for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Postmenopausal Vaginal Atrophy 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Postmenopausal Vaginal Atrophy market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

  • Understanding historical and forecasted epidemiological data for Postmenopausal Vaginal Atrophy covering 7MM from 2015-2025.

  • Segment level epidemiology and market split for Postmenopausal Vaginal Atrophy .

  • The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Postmenopausal Vaginal Atrophy .

  • The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Postmenopausal Vaginal Atrophy market trends.

  • Thorough market distribution based on market share for Postmenopausal Vaginal Atrophy .

Reasons to buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Postmenopausal Vaginal Atrophy market.

  • To understand the future market competition in the Postmenopausal Vaginal Atrophy market and Insightful review of the key market drivers and barriers.

  • Organize sales and marketing efforts by identifying the best opportunities for Postmenopausal Vaginal Atrophy in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

  • Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Postmenopausal Vaginal Atrophy - Market Insights, Epidemiology and Market Forecast - 2025

Table of Contents

1. Report Introduction

2. Postmenopausal Vaginal Atrophy Market Overview at a Glance
2.1. Total Market Share Distribution of Postmenopausal Vaginal Atrophy for 7 MM in 2016
2.2. Total Market Share Distribution of Postmenopausal Vaginal Atrophy for 7 MM in 2025

3. Postmenopausal Vaginal Atrophy
3.1.1. Overview
3.1.2. Symptoms
3.1.3. Pathophysiology
3.1.4. Staging
3.1.5. Diagnosis
3.1.6. Treatment

4. Epidemiology and Patient Population
4.1.1. United States
4.1.1.1. Diagnosed Cases of Postmenopausal Vaginal Atrophy in United States
4.1.2. Germany
4.1.2.1. Diagnosed Cases of Postmenopausal Vaginal Atrophy in Germany
4.1.3. France
4.1.3.1. Diagnosed Cases of Postmenopausal Vaginal Atrophy in France
4.1.4. Italy
4.1.4.1. Diagnosed Cases of Postmenopausal Vaginal Atrophy in Italy
4.1.5. Spain
4.1.5.1. Diagnosed Cases of Postmenopausal Vaginal Atrophy in Spain
4.1.6. United Kingdom
4.1.6.1. Diagnosed Cases of Postmenopausal Vaginal Atrophy in United Kingdom

5. Treatment Algorithm
5.1.1. Treatment Guidelines/Practices

6. Marketed Drugs for Postmenopausal Vaginal Atrophy
6.1. Drug 1: Company A
6.1.1. Drug Description
6.1.2. Mechanism of Action
6.1.3. Regulatory Milestones
6.1.4. Advantages & Disadvantages
6.1.5. Safety and Efficacy
6.1.6. Product Profile
6.1.7. Patent Status
6.2. Drug 2: Company B
6.2.1. Drug Description
6.2.2. Mechanism of Action
6.2.3. Regulatory Milestones
6.2.4. Advantages & Disadvantages
6.2.5. Safety and Efficacy
6.2.6. Product Profile
6.2.7. Patent Status

7. Emerging Therapies
7.1. Drug 3: Company C
7.1.1. Description
7.1.2. Regulatory Milestones
7.1.3. Advantages & Disadvantages
7.1.4. Product Profile
7.1.5. Launch Date
7.1.6. Clinical Development
7.1.7. Clinical Pipeline Activity
7.1.8. Ongoing Trials Information
7.1.9. Clinical Trial by Phase
7.2. Drug 4: Company B
7.2.1. Description
7.2.2. Regulatory Milestones
7.2.3. Advantages & Disadvantages
7.2.4. Product Profile
7.2.5. Launch Date
7.2.6. Clinical Development
7.2.7. Clinical Pipeline Activity
7.2.8. Ongoing Trials Information
7.2.9. Clinical Trial by Phase

8. Overview of Total Postmenopausal Vaginal Atrophy Market (2016 & 2025)

9. Postmenopausal Vaginal Atrophy : Country-Wise Market Analysis
9.1. United States
9.1.1. Historical Market Size (2015-2016)
9.1.2. Forecasted Market Size (2017-2025)
9.2. Germany Market Size
9.2.1. Historical Market Size (2015-2016)
9.2.2. Forecasted Market Size (2017-2025)
9.3. France Market Size
9.3.1. Historical Market Size (2015-2016)
9.3.2. Forecasted Market Size (2017-2025)
9.4. United Kingdom Market Size
9.4.1. Historical Market Size (2015-2016)
9.4.2. Forecasted Market Size (2017-2025)
9.5. Spain Market Size
9.5.1. Historical Market Size (2015-2016)
9.5.2. Forecasted Market Size (2017-2025)
9.6. Italy Market Size
9.6.1. Historical Market Size (2015-2016)
9.6.2. Forecasted Market Size (2017-2025)
9.7. Japan Market Size
9.7.1. Historical Market Size (2015-2016)
9.7.2. Forecasted Market Size (2017-2025)

10. Market Drivers

11. Market Restraints

12. Appendix

13. Report Methodology

14. Consulting Services

15. Disclaimer

16. About DelveInsight

List of Tables

Table 1: Diagnosed Cases Postmenopausal Vaginal Atrophy in United States (2015-2025)
Table 2: Diagnosed Cases Postmenopausal Vaginal Atrophy in Germany (2015-2025)
Table 3: Diagnosed Cases Postmenopausal Vaginal Atrophy in France (2015-2025)
Table 4: Diagnosed Cases Postmenopausal Vaginal Atrophy in United Kingdom (2015-2025)
Table 5: Diagnosed Cases Postmenopausal Vaginal Atrophy in Spain (2015-2025)
Table 6: Diagnosed Cases Postmenopausal Vaginal Atrophy in Italy (2015-2025)
Table 7: Diagnosed Cases Postmenopausal Vaginal Atrophy in Japan (2015-2025)
Table 8: List of Marketed Drugs for Postmenopausal Vaginal Atrophy
Table 9: List of Pipeline Phase III Drugs for Postmenopausal Vaginal Atrophy
Table 10: Drug 1, Clinical Trials by Zone, 2017
Table 11: Clinical Trials by Trial status, 2017
Table 12: Drug 2, Clinical Trials by Zone, 2017
Table 13: Clinical Trials by Trial status, 2017
Table 14: Drug 3, Clinical Trials by Zone, 2017
Table 15: Clinical Trials by Trial status, 2017
Table 16: United States Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
Table 17: Germany Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
Table 18: France Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
Table 19: United Kingdom Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
Table 20: Spain Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
Table 21: Italy Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
Table 22: Japan Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)

List of Figures

Figure 1: Diagnosed Cases Postmenopausal Vaginal Atrophy in United States (2015-2025)
Figure 2: Diagnosed Cases Postmenopausal Vaginal Atrophy in Germany (2015-2025)
Figure 3: Diagnosed Cases Postmenopausal Vaginal Atrophy in France (2015-2025)
Figure 4: Diagnosed Cases Postmenopausal Vaginal Atrophy in United Kingdom (2015-2025)
Figure 5: Diagnosed Cases Postmenopausal Vaginal Atrophy in Spain (2015-2025)
Figure 6: Diagnosed Cases Postmenopausal Vaginal Atrophy in Italy (2015-2025)
Figure 7: Diagnosed Cases Postmenopausal Vaginal Atrophy in Japan (2015-2025)
Figure 8: List of Marketed Drugs for Postmenopausal Vaginal Atrophy
Figure 9: List of Pipeline Phase III Drugs for Postmenopausal Vaginal Atrophy
Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
Figure 11: Clinical Trials by Trial status, 2017
Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
Figure 13: Clinical Trials by Trial status, 2017
Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
Figure 15: Clinical Trials by Trial status, 2017
Figure 16: United States Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
Figure 17: Germany Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
Figure 18: France Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
Figure 19: United Kingdom Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
Figure 20: Spain Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
Figure 21: Italy Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
Figure 22: Japan Market Size of Postmenopausal Vaginal Atrophy in USD, Million (2015-2025)
  • Global and Regional Postmenopausal Vaginal Atrophy Treatment Market Research Report 2017
    Published: 09-Dec-2017        Price: US 3500 Onwards        Pages: 128
    Summary Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase. Market Segment as follows: By Region - Asia-Pacific......
  • China Contraceptives Market Research Report 2017
    Published: 05-Dec-2017        Price: US 3400 Onwards        Pages: 107
    The global Contraceptives market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies the Contraceptives development status and future trend in China, focuses on top players in China, also splits Contraceptives b......
  • Global Contraceptives Market Professional Survey Report 2017
    Published: 24-Nov-2017        Price: US 3500 Onwards        Pages: 113
    This report studies Contraceptives in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Merck - Cipla Inc. - Allergan plc - Bayer AG - HLL Lifecare Li......
  • Global Topical Contraceptive Market Professional Survey Report 2017
    Published: 22-Nov-2017        Price: US 3500 Onwards        Pages: 128
    This report studies Topical Contraceptive in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Pfizer - Merck Millipore - Allergan - Mylan - Teva Phar......
  • 2017-2022 China Bacterial Vaginosis Drug Market Report (Status and Outlook)
    Published: 20-Nov-2017        Price: US 3360 Onwards        Pages: 124
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Bacterial Vaginosis Drug market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include - Bayer - Pfizer - Sanofi - Piramal - Abbott - Galderma - Mission - Alkem - Xiuzheng - Teva - Perrigo......
  • 2017-2022 Europe Top Countries Bacterial Vaginosis Drug Market Report
    Published: 20-Nov-2017        Price: US 4660 Onwards        Pages: 124
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Europe Bacterial Vaginosis Drug market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Bacterial Vaginosis Drug in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in Europe, focuses on the top players in each country, covering......
  • 2017-2022 Global Top Countries Bacterial Vaginosis Drug Market Report
    Published: 20-Nov-2017        Price: US 4960 Onwards        Pages: 124
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the global Bacterial Vaginosis Drug market size was xx million USD, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Bacterial Vaginosis Drug in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle E......
  • 2017-2022 India Bacterial Vaginosis Drug Market Report (Status and Outlook)
    Published: 20-Nov-2017        Price: US 3360 Onwards        Pages: 124
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Bacterial Vaginosis Drug market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In India market, the top players include - Bayer - Pfizer - Sanofi - Piramal - Abbott - Galderma - Mission - Alkem - Xiuzheng - Teva - P......
  • 2017-2022 North America Bacterial Vaginosis Drug Market Report
    Published: 20-Nov-2017        Price: US 4660 Onwards        Pages: 124
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the North America Bacterial Vaginosis Drug market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Bacterial Vaginosis Drug in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering - Bayer - Pfizer......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs